Lindenmayer JP - Search Results

1

Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.

Friedman JI, Lindenmayer JP, Alcantara F, Bowler S, Parak M, White L, Iskander A, Parrella M, Adler DN, Tsopelas ND, Tsai WY, Novakovic V, Harvey PD, Davis KL, Kaushik S. Friedman JI, et al. Among authors: lindenmayer jp. Neuropsychopharmacology. 2011 May;36(6):1289-95. doi: 10.1038/npp.2011.14. Epub 2011 Feb 23. Neuropsychopharmacology. 2011. PMID: 21346734 Free PMC article. Clinical Trial.

2

A randomized, double-blind, parallel-group, fixed-dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment-resistant schizophrenia or schizoaffective disorder.

Lindenmayer JP, Citrome L, Khan A, Kaushik S, Kaushik S. Lindenmayer JP, et al. J Clin Psychopharmacol. 2011 Apr;31(2):160-8. doi: 10.1097/JCP.0b013e31820f4fe0. J Clin Psychopharmacol. 2011. PMID: 21346616 Clinical Trial.

3

Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS).

Novakovic V, Adel T, Peselow E, Lindenmayer JP. Novakovic V, et al. Among authors: lindenmayer jp. Clin Neuropharmacol. 2013 Mar-Apr;36(2):59-62. doi: 10.1097/WNF.0b013e3182854f70. Clin Neuropharmacol. 2013. PMID: 23503549 Review.

4

Schizophrenia: measurements of psychopathology.

Lindenmayer JP, Harvey PD, Khan A, Kirkpatrick B. Lindenmayer JP, et al. Psychiatr Clin North Am. 2007 Sep;30(3):339-63. doi: 10.1016/j.psc.2007.04.005. Psychiatr Clin North Am. 2007. PMID: 17720027 Review.

5

A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.

Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B. Lindenmayer JP, et al. J Clin Psychiatry. 2007 Mar;68(3):368-79. doi: 10.4088/jcp.v68n0303. J Clin Psychiatry. 2007. PMID: 17388705 Clinical Trial.

6

Clozapine augmentation with aripiprazole for negative symptoms.

Clarke LA, Lindenmayer JP, Kaushik S. Clarke LA, et al. Among authors: lindenmayer jp. J Clin Psychiatry. 2006 Apr;67(4):675-6. doi: 10.4088/jcp.v67n0420d. J Clin Psychiatry. 2006. PMID: 16669737 No abstract available.

7

Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group.

White L, Harvey PD, Opler L, Lindenmayer JP. White L, et al. Among authors: lindenmayer jp. Psychopathology. 1997;30(5):263-74. doi: 10.1159/000285058. Psychopathology. 1997. PMID: 9353855

8

Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia.

Lindenmayer JP, Tedeschi F, Yusim A, Khan A, Kaushik S, Smith RC, Parakadavil M. Lindenmayer JP, et al. Clin Schizophr Relat Psychoses. 2012 Jan;5(4):185-92. doi: 10.3371/CSRP.5.4.2. Clin Schizophr Relat Psychoses. 2012. PMID: 22182455

9

Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study.

Lindenmayer JP, Iskander A, Park M, Apergi FS, Czobor P, Smith R, Allen D. Lindenmayer JP, et al. J Clin Psychiatry. 1998 Oct;59(10):521-7. doi: 10.4088/jcp.v59n1005. J Clin Psychiatry. 1998. PMID: 9818633 Clinical Trial.

10

Improved long-term outcome with long-acting risperidone treatment of chronic schizophrenia with prior partial response.

Lindenmayer JP, Parak M, Gorman JM. Lindenmayer JP, et al. J Psychiatr Pract. 2006 Jan;12(1):55-7. doi: 10.1097/00131746-200601000-00009. J Psychiatr Pract. 2006. PMID: 16432447 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters